WETS
BIIB icon

Wealth Enhancement Trust Services’s Biogen BIIB Stock Holding History

Wealth Enhancement Trust Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
468
+88
+23% +$16.8K 0.01% 368
2026
Q1 		$69.7K Buy
+380
New +$70K 0.01% 404

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wealth Enhancement Trust Services's BIIB Position: Q2 2026 in Review

Wealth Enhancement Trust Services increased its Biogen (BIIB) stake by 23% in Q2 2026, buying an estimated $16.8K and bringing the position to 468 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #368.

Wealth Enhancement Trust Services first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Wealth Enhancement Trust Services held 468 shares of Biogen worth $101K as of Q2 2026.
  • Wealth Enhancement Trust Services bought 88 Biogen shares in Q2 2026, an estimated $16.8K.
  • Biogen made up 0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #368 holding.
  • Wealth Enhancement Trust Services first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.